To: Paul Engel who wrote (83811 ) 6/18/1999 1:10:00 PM From: Maverick Respond to of 186894
For the 2nd consecutive day, Wall Street is saying negative things about this leading chip maker. Yesterday, CS First Boston cut estimates for FY99 from $2.32 to $2.25 and FY00 EPS from $2.65 to $2.55 as the firm expects Intel's fiscal Q2 earnings to come in a penny shy of current Wall Street projections due to lower unit shipments and lower processor average selling prices. However, CS First Boston maintained its "buy" rating on the stock. This time around, Morgan Stanley Dean Witter downgraded the semiconductor maker from "strong buy" to "market outperform" and cut FY99 and FY00 EPS estimates from $2.35 and $2.60 per share, to $2.25 and $2.55 per share, respectively. The decision to lower estimates and downgrade the stock stems from talks with management that indicated that the 0.18 micron manufacturing process of Pentium III processors will see some delays. Hence, since 0.18 micron production will be pushed out, Morgan Stanley expects that this will lead to lower average selling prices for the remaining Intel products. Given that Intel is due to report Q2 earnings in mid-July, these two latest research reports do not bode well for the stock. In fact, the stock has been relegated to a trading range for the past several months, trading between $50 and $60 (adjusted for a 2-1 stock split in April) and is not expected to see the upper end of this range for at least the next couple of weeks. While the stock was trading just above $60 at the beginning of 1999 and reached a high of $71 27/32 shortly thereafter, it has been all downhill since then. The next few weeks will be tough for investors as they sit and wait for Intel's Q2 report which will dictate how soon this stock regains its luster again. - RN